Search research articles
Contact Us
Filters
Showing results (231-240 of 409) with videos related to
Page
of 41
Sort By:
Diabetologia
|
May 26, 2010
The suppressor of cytokine signalling 2 (SOCS2) is a key repressor of insulin secretion
P Lebrun, E Cognard, P Gontard, et al.
Diabetologia
|
August 13, 2009
Constitutive expression of suppressor of cytokine signalling-3 in skeletal muscle leads to reduced mobility and overweight in mice
P Lebrun, E Cognard, R Bellon-Paul, et al.
Gynecologic Oncology
|
January 18, 2016
First application of the Automated QUantitative Analysis (AQUA) technique to quantify PTEN protein expression in ovarian cancer: A correlative study of NCIC CTG OV.16
J I Weberpals, M S Amin, B E Chen, et al.
Annales D'Endocrinologie
|
April 6, 1999
[INSERM-FNCLCC collective expert's report. Recommendations for management of women having a genetic risk of developing breast and/or ovarian cancer. National Federation of Centers of the Fight Against Cancer]
F Eisinger, N Alby, A Bremond, et al.
Annales De Genetique
|
April 24, 1999
[INSERM-FNCLCC collective expertise. Recommendations for medical management of women with genetic risk of developing breast and/or ovarian cancer]
F Eisinger, N Alby, A Bremond, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 18, 1998
Recommendations for medical management of hereditary breast and ovarian cancer: the French National Ad Hoc Committee
F Eisinger, N Alby, A Bremond, et al.
Bulletin Du Cancer
|
April 22, 1999
[Inserm ad hoc committee: Recommendations for the management of women with a genetic risk for developing cancer of the breast and/or the ovary]
F Eisinger, N Alby, A Bremond, et al.
Leukemia & Lymphoma
|
January 17, 2020
Objective quantification of BCL2 protein by multiplex immunofluorescence in routine biopsy samples of diffuse large B-cell lymphoma demonstrates associations with survival and <i>BCL2</i> gene alterations
Lina Chen, Kathrin Tyryshkin, Alison Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2013
MicroRNA signature obtained from the comparison of aggressive with indolent non-Hodgkin lymphomas: potential prognostic value in mantle-cell lymphoma
Rashmi S Goswami, Eshetu G Atenafu, Yali Xuan, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences
|
February 21, 2018
AEgIS at ELENA: outlook for physics with a pulsed cold antihydrogen beam
M Doser, S Aghion, C Amsler, et al.
Page
of 41
Search research articles
Search
Showing results (231-240 of 409) with videos related to
Sort By:
Page
of 41
Diabetologia
|
May 26, 2010
The suppressor of cytokine signalling 2 (SOCS2) is a key repressor of insulin secretion
P Lebrun, E Cognard, P Gontard, et al.
Diabetologia
|
August 13, 2009
Constitutive expression of suppressor of cytokine signalling-3 in skeletal muscle leads to reduced mobility and overweight in mice
P Lebrun, E Cognard, R Bellon-Paul, et al.
Gynecologic Oncology
|
January 18, 2016
First application of the Automated QUantitative Analysis (AQUA) technique to quantify PTEN protein expression in ovarian cancer: A correlative study of NCIC CTG OV.16
J I Weberpals, M S Amin, B E Chen, et al.
Annales D'Endocrinologie
|
April 6, 1999
[INSERM-FNCLCC collective expert's report. Recommendations for management of women having a genetic risk of developing breast and/or ovarian cancer. National Federation of Centers of the Fight Against Cancer]
F Eisinger, N Alby, A Bremond, et al.
Annales De Genetique
|
April 24, 1999
[INSERM-FNCLCC collective expertise. Recommendations for medical management of women with genetic risk of developing breast and/or ovarian cancer]
F Eisinger, N Alby, A Bremond, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 18, 1998
Recommendations for medical management of hereditary breast and ovarian cancer: the French National Ad Hoc Committee
F Eisinger, N Alby, A Bremond, et al.
Bulletin Du Cancer
|
April 22, 1999
[Inserm ad hoc committee: Recommendations for the management of women with a genetic risk for developing cancer of the breast and/or the ovary]
F Eisinger, N Alby, A Bremond, et al.
Leukemia & Lymphoma
|
January 17, 2020
Objective quantification of BCL2 protein by multiplex immunofluorescence in routine biopsy samples of diffuse large B-cell lymphoma demonstrates associations with survival and <i>BCL2</i> gene alterations
Lina Chen, Kathrin Tyryshkin, Alison Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 10, 2013
MicroRNA signature obtained from the comparison of aggressive with indolent non-Hodgkin lymphomas: potential prognostic value in mantle-cell lymphoma
Rashmi S Goswami, Eshetu G Atenafu, Yali Xuan, et al.
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences
|
February 21, 2018
AEgIS at ELENA: outlook for physics with a pulsed cold antihydrogen beam
M Doser, S Aghion, C Amsler, et al.
Page
of 41